In-Person Access Only | 7.50 CE/CME Credits & MOC Points
The 10th Annual West Oncology Conference served as a valuable forum for presenting and discussing new research findings in oncology education.
Learners were provided updates on practice-changing data in breast cancers, genitourinary cancers, hematological malignancies, gastrointestinal cancers, and lung cancers – all in a practical and interactive format, fostering discussion and impacting patient clinical outcomes. This accredited meeting was an in-person conference with on-demand access for registered attendees.
Program Chairs
Jason Chandler, MD | West Cancer Center
Brad Somer, MD | West Cancer Center
Gregory Vidal, MD, PhD | West Cancer Center
Speakers
Ramakrishna Battini, MD | West Cancer Center
Erin Cobain, MD | University of Michigan
Amber Fifield, PhD | Caris
Axel Grothey, MD | West Cancer Center
Heinz-Josef Lenz, MD | Keck Medicine of USC
Alyssa Pittman, MD | West Cancer Center
Lee Schwartzberg, MD, FACP | Renown Health
Daniel Vaena, MD | West Cancer Center
Lauren Welch MSN, NP-C, AOCNP | Medical Affairs - Guardant Health
Tian Zhang, MD | UT Southwestern Medical Center
Anna Beth Bradley, MD | Vanderbilt University Medical Center
Paxton Dickson, MD | The University of Tennessee Health Science Center
Holger Gieschen, MD | West Cancer Center
Fred Hirsch, MD, PhD | Mount Sinai
Sami Mansfield, BA, ACSM-CET | Cancer Wellness for Life
Jason Porter, MD | West Cancer Center
Erica Stringer-Reasor, MD | UAB Medicine
Brian Van Tine, MD, PhD | Washington University in St. Louis
William Wierda, MD, PhD | MD Anderson Cancer Center
David Carbone, MD, PHD | The Ohio State University
Douglas Flora, MD | St. Elizabeth Healthcare
Richard Gilmore, MD | West Cancer Center
Tyler Johnson, MD | Stanford University
Charles Nguyen, MD | City of Hope
Pierluigi Porcu, MD | Jefferson University
Leah Tonkin, MD, MBA, DipABLM | West Cancer Center
Noam Vanderwalde, MD, MS | West Cancer Center
George Yaghmour, MD | Keck Medicine of USC
Conference Agenda Saturday, February 8, 2025
8:00 AM
Coffee and Exhibits
8:30 AM
Program Chair Welcome
8:35 AM
Lifestyle Tips and Strategies Sami Mansfield, BA, ACSM-CET | Cancer Wellness for Life
8:40 AM
Updates in Colorectal Cancer Heinz-Josef Lenz, MD | Keck Medicine of USC
9:00 AM
Updates in Non-Colorectal Cancer Tyler Johnson, MD | Stanford University
9:20 AM
Panel Discussion and Q&A - Gastrointestinal Cancer Axel Grothey, MD (Moderator) | West Cancer Center Tyler Johnson, MD | Stanford University Heather Greene, MSN, FNP, AOCNP | West Cancer Center Paxton Dickson, MD | The University of Tennessee Health Science Center Noam Vanderwalde, MD, MS | West Cancer Center Heinz-Josef Lenz, MD | Keck Medicine of USC
9:40 AM
Neoadjuvant vs Adjuvant: A New Paradigm for NSCLC David Carbone, MD, PHD | The Ohio State University
10:00 AM
Established and New Target Therapies in NSCLC Fred Hirsch, MD, PhD | Mount Sinai
10:20 AM
Panel Discussion and Q&A - Lung Cancer Ramakrishna Battini, MD (Moderator) | West Cancer Center Jason Porter, MD | West Cancer Center Holger Gieschen, MD | West Cancer Center David Carbone, MD, PHD | The Ohio State University Fred Hirsch, MD, PhD | Mount Sinai
10:40 AM
Breakfast and Exhibits
10:55 AM
Breakfast and Learn - 10 Years of Cancer Care in Memphis
Sarah Louden | Total Health Oncology
Brad Somer, MD | West Cancer Center
Gregory Vidal, MD, PhD | West Cancer Center
Jason Chandler, MD | West Cancer Center
11:25 AM
Updates in CLL William Wierda, MD, PhD | MD Anderson Cancer Center
11:45 AM
Cutaneous T Cell Lymphoma Pierluigi Porcu, MD | Jefferson University
12:05 PM
Updates on Acute Lymphoblastic Leukemia George Yaghmour, MD | Keck Medicinve of USC
12:25 PM
Panel Discussion and Q&A - Hematological Malignancies Jason Chandler, MD (Moderator) | West Cancer Center Pierluigi Porcu, MD | Jefferson University George Yaghmour, MD | Keck Medicine of USC William Wierda, MD, PhD | MD Anderson Cancer Center
12:45 AM
Lifestyle Tips and Strategies Sami Mansfield, BA, ACSM-CET | Cancer Wellness for Life
12:50 PM
Lunch and Exhibits
1:05 PM
Non-CME Lunch -Pfizer - Treatment Considerations for Specific Populations With HR+/HER2- mBC
Anne O’Dea, MD University of Kansas Cancer Center
1:50 PM
Housekeeping and Survey
1:55 PM
Molecular Tumor Board Panel Axel Grothey, MD (Moderator) | West Cancer Center Amber Fifield, PhD | Caris Lauren Welch MSN, NP-C, AOCNP | Medical Affairs - Guardant Health Lee Schwartzberg, MD, FACP | Renown Health
2:35 PM
Cellular Therapy For Solid Tumor - Where are we now and where are we going? Brian Van Tine, MD, PhD | Washington University in St. Louis
3:05 PM
Networking Reception
3:35 PM
Adjourn
Sunday, February 9, 2025
8:00 AM
Coffee and Exhibits
8:30 AM
Program Chair Welcome
8:35 AM
Lifestyle Tips and Strategies Sami Mansfield, BA, ACSM-CET | Cancer Wellness for Life
8:40 AM
Updates in Non-Prostate Cancer Charles Nguyen, MD | City of Hope
9:00 AM
Updates in Prostate Cancer Tian Zhang, MD | UT Southwestern Medical Center
9:20 AM
Panel Discussion and Q&A - Genitourinary Cancer Brad Somer, MD (Moderator) | West Cancer Center Charles Nguyen, MD | City of Hope Daniel Vaena, MD | West Cancer Center Tian Zhang, MD | UT Southwestern Medical Center
9:35 AM
Breakfast and Exhibits
9:50 AM
Non-CME Breakfast - Natera - Personalized ctDNA testing for MRD assessment to inform treatment in patients with solid tumors
Gina Vacaro, MD | Tennessee Oncology
10:35 AM
Lifestyle Tips and Strategies Sami Mansfield, BA, ACSM-CET | Cancer Wellness for Life
10:40 AM
Where is AI going in Oncology? Douglas Flora, MD | St. Elizabeth Healthcare
11:10 AM
Pharmacologic Management of Obesity Anna Bradley, MD | Vanderbilt University Medical Center
11:25 AM
Obesity Epidemic - Attacking America's Biggest Carcinogen Brad Somer, MD (Moderator) | West Cancer Center Sami Mansfield, BA, ACSM-CET | Cancer Wellness for Life Leah Tonkin, MD, MBA, DipABLM | West Cancer Center Anna Bradley, MD | Vanderbilt University Medical Center
11:55 AM
K-RAS Targeting – The Cusp of a Game Changer Target Axel Grothey, MD | West Cancer Center
12:15 PM
Lunch and Exhibits
12:30 PM
Non-CME Lunch - Stemline - In ESR1m, ER+/HER2- mBC following progression on endocrine therapy. Upon 1L Progression, Discover the Path Forward With ORSERDU for Patients With ESR1m
Martin Dietrich, MD, PhD | University of Central Florida College of Medicine Lake Mary FL
1:15 PM
Lifestyle Tips and Strategies Sami Mansfield, BA, ACSM-CET | Cancer Wellness for Life
1:20 PM
Management of Metastatic Hormone Receptor Positive Breast Cancer Erica Stringer-Reasor, MD | UAB Medicine
1:40 PM
CNS Management HER+ Erin Cobain, MD | University of Michigan
2:00 PM
Panel Discussion and Q&A - Breast Cancer Gregory Vidal, MD, PhD (Moderator) | West Cancer Center Alyssa Pittman, MD | West Cancer Center Erica Stringer-Reasor, MD | UAB Medicine Erin Cobain, MD | University of Michigan Noam Vanderwalde, MD, MS | West Cancer Center Richard Gilmore, MD | West Cancer Center
2:15 PM
Adjourn
Agenda Subject To Change. All times are CST.
-
Identify novel targeted and immunologic approaches to therapy for various cancers
Integrate recent findings on healthcare disparities into optimal therapy selection for individual patients with cancer
Identify optimal therapies for patients and managing and mitigating side effects
Describe findings from recent clinical trials evaluating immunotherapies
Identify strategies to prevent and manage the treatment related adverse events of targeted therapies and immunotherapies to improve tolerability and maintain quality of life
Foster discussions on equitable and equal access and delivery of care for disparate populations, including discussing research and drug and diagnostic pipeline development that include underserved and underrepresented patients
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 7.50 ANCC contact hours.Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 7.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 7.50 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Enduring video content for watching at your leisure
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program